SCHEMBL6601154

SCHEMBL6601154

COc1ccc(C2=NN(C(=O)c3cccc(NC(=O)c4ccco4)c3)CCC2)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.50
HTT P42858 2/20 0.50
TSHR P16473 3/20 0.49
MAPK1 P28482 3/20 0.49
NPSR1 Q6W5P4 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPT P10636 5/20 0.49
LMNA P02545 2/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
RAB9A P51151 3/20 0.47
USP2 O75604 1/20 0.47
GAA P10253 1/20 0.47
HSD17B10 Q99714 1/20 0.47
NPC1 O15118 2/20 0.46
TP53 P04637 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6605494 0.94 MAPT (0.51) SMN1; SMN2HTTTSHRMAPK1NPSR1
SCHEMBL6603286 0.92 PDE5A (0.47) SMN1; SMN2HTTTSHRMAPK1NPSR1
SCHEMBL6600737 0.92 NPSR1 (0.54) SMN1; SMN2HTTTSHRMAPK1NPSR1
SCHEMBL6606976 0.88 MAOB (0.45) SMN1; SMN2MAPK1NPSR1MAPTLMNA
SCHEMBL6604071 0.86 MAOB (0.54) SMN1; SMN2HTTNPSR1MAPTLMNA
SCHEMBL6603384 0.86 MAOB (0.52) SMN1; SMN2HTTNPSR1MAPTLMNA
SCHEMBL6601909 0.85 MAPT (0.52) SMN1; SMN2TSHRMAPK1NPSR1CYP1A2
SCHEMBL6602165 0.85 MAOB (0.48) SMN1; SMN2NPSR1CYP1A2CYP3A4MAPT
SCHEMBL6602100 0.85 MAOB (0.48) SMN1; SMN2HTTMAPK1NPSR1CYP1A2
SCHEMBL6604786 0.85 TSHR (0.47) SMN1; SMN2HTTTSHRMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed